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SUMMARY
We investigate the impact of the tumor microvascular geometry on transport of drugs in solid tumors,
in particular focusing on the diffusion and consumption phenomena. We embrace recent advances in the
asymptotic homogenization literature starting from a double Darcy, double advection-diffusion-reaction
system of partial differential equations which is obtained exploiting the sharp length separation between
the intercapillary distance and the average tumor size. The geometric information on the microvascular
network is encoded into effective hydraulic conductivities and diffusivities, which are numerically computed
by solving periodic cell problems on appropriate microscale representative cells. The coefficients are then
injected into the macroscale equations, which are solved for an isolated, vascularized spherical tumor.
We consider the effect of vascular tortuosity on the transport of anti-cancer molecules, focusing on the
Vinblastine and Doxorubicin dynamics, which can be considered a tracer and a highly interacting molecule,
respectively. The computational model is able to quantify the performance of the treatment through the
analysis of the interstitial drug concentration and the quantity of drug metabolized in the tumor. Our results
show that both drug advection and diffusion are dramatically impaired by increasing geometrical complexity
of the microvasculature, leading to non-optimal absorption and delivery of therapeutic agents. However, this
effect apparently has a minor role whenever the dynamics are mostly driven by metabolic reactions in the
tumor interstitium, i.e. for highly interacting molecules. In the latter case, anti-cancer therapies that aim at
regularizing the microvasculature might not play a major role and different strategies are to be developed.
Copyright c© 2010 John Wiley & Sons, Ltd.
Received . . .
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1. INTRODUCTION
A tumor mass needs nutrients supply to grow beyond a certain size. This is achieved via the
angiogenesis process, i.e. the tumor cells secrete factors that stimulate the formation of a new
vasculature [1]. The tumor microvasculature is significantly more disorganized, tortuous and leaking
∗Correspondence to: raimondo.penta@upm.es
Copyright c© 2010 John Wiley & Sons, Ltd.
Prepared using cnmauth.cls [Version: 2010/03/27 v2.00]
2 P.MASCHERONI AND R.PENTA
(exhibiting large fenestrations) compared against its healthy counterpart. As a result, the normal
circulation of blood and dispersed molecules may be compromised. Moreover, proliferating cancer
cells alter the tumor microenvironment, collapsing blood and lymphatic vessels and destroying
the physiological fluid flow [2]. Fluid accumulates in the interstitium, causing the interstitial fluid
pressure to rise almost reaching the pressure level in the capillary network. Convective transport
between the vascular and interstitial compartments - mainly driven by the transvascular pressure
jump - is thus dramatically hindered, reducing mass exchange between the tumor and the vessels [3].
Therefore, malignant vascularization acts as an effective barrier, compromising the fluid transport
and the delivery of therapeutic agents in the tumor [4], [5]. Relevant Experimental work (see,
e.g. [6]), as well as mathematical models concerning tumor-induced angiogenesis (see, e.g. the
review work [7]) and transport and consumption of drugs (see, e.g. [8]) can play a key role
in elucidating the complex mechanisms and determinants underlying these phenomena and may
contribute to the development of anti-cancer therapies. The aim of this work is to analyze the
dependence of drug transport (in terms of advection, diffusion, and reaction) on the geometrical
and physiological features of the tumor microvasculature. We start from the model presented in [9],
where the authors apply asymptotic (periodic) homogenization [10] to derive a double Darcy, double
advection-diffusion-reaction model describing the fluid and drug dynamics on the tissue scale.
Balance equations for the fluid are upscaled starting from Darcy’s law and the Stokes problem in
the tumor interstitium and the capillary network, respectively. The dynamics and space distribution
of a generic drug are formally described by an advection-diffusion model in both compartments,
and possible drug uptake mechanisms are considered explicitly in the tumor interstitium. The
mass and drug exchange through the capillary membrane is addressed via the non equilibrium
thermodynamical model originally due to [11] and then developed in [12] and depends on the
pressures and concentrations jumps across the vessels walls. These contributions translate into
effective mass sources and reaction terms on the macroscale. The asymptotic homogenization
upscaling process leads to a computationally feasible model, which can be solved on a coarse grid as
only macroscale variations are to be resolved. However, the information concerning the microscale
is encoded in the model coefficients, namely, the effective conductivities and diffusivities. These
coefficients are to be computed solving classical differential problems on a periodic representative
cell. In [13], the authors solve the fluid transport model developed in [14] (which can be derived as a
particular case of [9] for negligible diffusion), computing the effective hydraulic conductivities for a
number of prototypical geometries at increasing tortuosity. They deduce that geometrical tortuosity
leads to impaired blood (and hence drug) advection within the tumor mass. Here, we extend their
work by solving for the first time the multiscale model derived in [9] (under a number of simplifying
assumptions) for different anti-cancer molecules and drug fluxes across the capillary walls. We
recover the macroscale diffusivity tensors by solving Laplace-type cell problems at increasing
vascular tortuosity. We track the macroscale drug concentration profile accounting for the effects
of microvascular tortuosity on molecule diffusivity and uptake within the tumor mass.
The remainder of this work, which is intended to be the full-length version of the results briefly
presented in [15], is organized as follows:
• In Section 2 we summarize the homogenized mathematical model [9], which is the starting
point of the present analysis.
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• In Section 3, we describe the microscale and macroscale computational approach embraced in
this work and the report the cell problems’ solution, as well as the appropriate physiological
parameters taken (or estimated) from the experimental literature.
• In Section 4, we present the macroscopic model results and discuss the effects of
microvascular tortuosity on drug transport in the tumor. We apply our mathematical
framework to three different therapeutic agents and report on the model outcomes in terms
of interstitial drug concentration and amount of metabolized drug.
• Finally, in Section 5 we present concluding remarks and further perspectives.
2. MATHEMATICAL MODELING
In [9], the authors extend the multiscale analysis presented in [14] to describe the interplay
between the fluid and drug dynamics in vascularized tumors via a coupled double Darcy, double
advection-diffusion-reaction system of PDEs at the tissue scale. On the local scale (identified by the
intercapillary distance), the network of blood vessels and the tumor interstitium are considered as
individual regions. Fluid transport is described by the Stokes’ and Darcy’s governing equations
in the interstitial and capillary network compartments, respectively. Drug transport is governed
by advection and diffusion of macromolecules in both compartments, together with possible
consumption mechanisms in the tumor interstitium. Blood and drug exchange across the capillary
walls is addressed via continuity of the corresponding fluxes, which are prescribed according to a
fully non-equilibrium thermodynamical approach [11]. Blood flux is proportional to the hydrostatic
pressure drop and to the osmotic pressure difference (due to the difference in drug concentrations),
while drug flux comprises both a convective contribution (proportional to the blood flux), and a
diffusive one related to the drug concentration jump. The multiscale homogenization approach
carried out in [9] relies on the sharp scales separation between the intercapillary distance d (≈ 50µm)
and the tumor size L under consideration (≈ 1cm). According to [9], we then denote by  the ratio
between the two scales, i.e.
 =
d
L
≪ 1 (1)
and we define two formally independent spatial variables y and x related by:
y =
x

(2)
spanning the microscale and macroscale, respectively. We further enforce y-periodicity and identify
the microstructure with a periodic cell Ω and its interstitial and capillary portions by Ωt and Ωn,
respectively, see Fig. 1. Enforcing asymptotic homogenization (see, e.g. [16, 17, 10]), we represent
every field in terms of the two independent spatial variables defined in Equation (2) and express
the solution in power series of the parameter . The upscaling process then provides a closed
system of PDEs at the macroscale for the leading order components of the relevant fields, and
represents the homogenized solution for vanishing . The geometric information at the microscale
is not lost, as it is encoded in the arising effective hydraulic conductivity and diffusivity tensors.
These auxiliary quantities are to be computed solving classical differential problems defined locally
on a representative periodic cell. The final set of homogenized equations describes both the fluid
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Figure 1. A 2D sketch of the microscale (right) vs the macroscale (left). On the macroscale, characterized
by the homogenized domain ΩH , the microscopic variations are smoothed out; on the microscale, the
difference between the interstitial (Ωt) and capillary (Ωn) compartments in the periodic cell is highlighted.
The microstructure is only locally periodic, and can vary over the macroscale.
and the drug dynamics in the tumor interstitium and vascular network at the tissue scale, while local
fluid and drug exchange across the capillary walls translates into effective mass and reaction terms
at the tissue scale.
In this work we aim at determining the impact of geometrical complexity on macromolecules
diffusion, and how macroscopic diffusion affects, in turn, drug delivery and consumption in the
tumor mass. Here we enforce the geometrical setup implemented in [13] for the blood transport
problem, where a parametric analysis at varying tortuosity for a single periodic cell is performed.
Therefore, we consistently specialize the non-dimensional tissue scale system of PDEs derived in
[9] to the specific case of macroscopic uniformity, i.e. we neglect macroscopic variations of the
microstructure. In the reminder of this work, we use the same notation convention reported in [9],
denoting scalar, vectorial, and second rank tensorial quantities via different fonts, i.e. a, a, and A
(with components Aij), respectively, for the sake of clarity. The subscripts n and t stand for the
capillary network and the interstitial compartment, respectively.
Thus, the governing equations for the fluid transport problem read
∇x · (K∇xpn) = S|Ωn| Φ¯b (3)
∇x · (κ¯E∇xpt) = − S|Ωt| Φ¯b, (4)
whereas for transport of macromolecules, assuming a linearized interstitial uptake rate:
∂tcn +∇x · (cn 〈un〉n − Dn∇xcn) = −
S
|Ωn| Φ¯d (5)
∂tct +∇x · (ct 〈ut〉t − Dt∇xct) =
S
|Ωt| Φ¯d −Da ct (6)
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where Darcy’s velocities are given by:
〈un〉n = −K∇xpn (7)
〈ut〉t = −κ¯E∇xpt, (8)
Here pn and pt are the leading macroscopic capillary and interstitial pressure fields, respectively, and
cn and ct are the corresponding leading drug concentrations. The two velocities un and ut are the
leading order average Darcy velocities (with non-dimensional hydraulic conductivities K and κ¯E)
describing fluid flow at the tissue scale. Note that Equations (3)-(8) are meant to be solved for every
x in the macroscopic homogenized domain ΩH . The reaction terms Φ¯b and Φ¯d appearing on the
right hand side of Equations (3)-(6) represent blood and drug fluxes, respectively. When a complete
Kedem-Katchalsky formulation is assumed [11], the resulting non-dimensional fluxes read:
Φ¯b = L¯p (pn − pt)− Π¯ (cn − ct) (9)
Φ¯d = (1− σ) cmΦ¯b + Υ¯ (cn − ct) (10)
Here σ is the osmotic reflection coefficient (0 < σ < 1). This parameter quantifies the departure of
a membrane behavior from semipermeability, being unitary for an ideal semipermeable membrane
and zero for an unselective membrane. In general, the value of σ depends on the solute being
considered and on the relative size of molecules and pores radii. Also, cm denotes an average
measure of the concentration within capillary walls. In [18] it is suggested to be a nonlinear function
of the fluid flux:
cm = (1− f)cn + fct, f = 1
γΦb
− 1
exp (γΦb)− 1 , γ =
1− σ
P
(11)
Here γΦb is the transvascular Pe´cle´t number (Pe) and expresses the relative importance of
convection with respect to diffusion across the capillary surface. For suitable values of Pe the
expression in Equation (11) can be linearized as:
Pe≫ 1 : Φ¯d = (1− σ) cnΦ¯b + Υ¯ (cn − ct) (12)
Pe≪ 1 : Φ¯d = (1− σ) c¯ Φ¯b + Υ¯ (cn − ct) , c¯ = 1
2
(cn + ct) (13)
An estimate of Pe for our system will be given in the next sections, together with the corresponding
form for the drug flux. The non-dimensional numbers L¯p, κ¯, Υ¯ and Da are the hydraulic permeability
of the vessel walls, the interstitial conductivity, the diffusive permeability of the capillary membrane
and the Damko¨hler number, respectively; Π¯ measures the relative importance of osmotic and fluid
pressure drop across the vessel wall. These quantities are defined by the following non-dimensional
numbers:
L¯p =
LpL
2µ
d3
, Π¯ =
LpLµσRTCr
Cd3
, κ¯ =
kµ
d2
, Υ¯ =
PµL
Cd3
, Da =
λLµ
Cd2
(14)
where Lp is the hydraulic conductivity of the vessel walls and µ is the effective viscosity of blood.
Note that here we are assuming a constant value for the latter parameter, neglecting the actual
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non-Newtonian nature of blood for the sake of simplicity. Then, R is the universal gas constant,
T is the absolute temperature, Cr and C are a reference drug concentration and pressure gradient,
respectively. Finally, k is the hydraulic conductivity of the tissue, P is the diffusive permeability of
the vessel walls and λ is the uptake rate in the interstitium. The representative cell exchange surface
area S and volumes |Ωn|, |Ωt| are defined by:
|Ωα| =
∫
Ωα
dy, α = n, t; S =
∫
Γ
dSy (15)
The conductivity tensors K and E are defined by:
K = 〈W〉n, E = I− 〈(∇yPt)T〉t (16)
where I denotes the second order identity tensor and the brackets 〈·〉α stand for the cell average
operator:
〈·〉α = 1|Ωα|
∫
Ωα
· dy, α = n, t (17)
The auxiliary tensors W(y) and Pt(y) satisfy the following cell problems:
∇2yWT −∇yPn + I = 0 in Ωn (18)
∇y ·WT = 0 in Ωn (19)
WTn = 0 on Γ (20)
WTτ = 0 on Γ (21)
∇2yPt = 0 in Ωt (22)
(∇yPt)n = n on Γ (23)
where the auxiliary quantities Pn and Pt fulfill the uniqueness conditions:
〈Pn〉n = 0 in Ωn and 〈Pt〉t = 0 in Ωt (24)
The other two tensors Dn and Dt in Equations (5)-(6) are the effective diffusivities for the capillary
and interstitial compartments, respectively. They are given by the formula:
Dn = An
(
I− 〈(∇ya)T〉n
)
, Dt = At
(
I− 〈(∇yb)T〉t
)
(25)
where An and At are the non-dimensional diffusivities for the two compartments:
An =
Dnµ
LCd2
, At =
Dtµ
LCd2
(26)
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and Dn, Dt are their dimensional counterparts. The auxiliary vectors a and b satisfy the cell
problems:
∇2ya = 0 in Ωn (27)
(∇ya)n = n on Γ (28)
∇2yb = 0 in Ωt (29)
(∇yb)n = n on Γ (30)
where, again, a further condition on a and b for their uniqueness is required, namely:
〈a〉n = 0 in Ωn, 〈b〉t = 0 in Ωt (31)
Exploiting periodicity in the y-variable, the cell problems for the previous tensor quantities are
closed by periodic conditions on the cell boundaries Ωn \ Γ and Ωt \ Γ for the corresponding
compartments. Note that the cell problems are actually classical differential problems, since
Equations (18)-(21) is a Stokes’ type boundary value problem and Equations (22)-(23),(27)-
(28),(29)-(30) are inhomogeneous Laplace problems.
In the next section we provide a detailed description of the computational setup and physiological
parameters that we have exploited to solve the microscale periodic cell problems and, in turn the
fluid and drug transport problem on the tissue scale. We start illustrating (a) a suitable algorithm
to obtain the solution of the problem in a few simple steps for macroscopically uniform structures,
(b) the physiological parameters exploited in the computations, (c) the microscale cell problem
computational setup for a tortuous microvasculature, (d) the macroscale problem for a spherical,
tissue scale tumor geometry.
3. MICROSCALE AND MACROSCALE COMPUTATIONAL SETUP
The computational steps needed to calculate the solution of the macroscale problem (3)-(8) can be
summarized as follows
• Given a time interval (0, T ) and the macroscale spatial domain ΩH , fix suitable initial and
boundary conditions.
• Set the model parameters and calculate the non-dimensional numbers in Equation (14)
• Set the representative cell and compute the geometrical parameters |Ωn|, |Ωt| and S.
• Solve the cell problems (18)-(24) and (27)-(31) to find the auxiliary quantities W,Pt,Pn,a
and b.
• Compute the effective conductivities and diffusivities K,E,Dn and Dt using Equations (16)
and (25).
• Solve the differential problem in Equations (3)-(8) supplemented by the initial and boundary
conditions given in the first step.
Copyright c© 2010 John Wiley & Sons, Ltd. Int. J. Numer. Meth. Biomed. Engng. (2010)
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We emphasize that the mathematical model is to be solved on the homogenized domain ΩH ,
nonetheless retaining all the relevant physical phenomena in the effective coefficients. A numerical
solution of the original problem would require an extremely refined spatial discretization to capture
all the details of the microstructure. However, since the effective governing Equations (3)-(6)
are defined on the macroscale domain, a significantly coarser grid can be used. The geometric
features of the microscale are now encoded into four constant symmetric positive definite tensors,
namely the capillary and interstitial effective hydraulic conductivities and diffusivities. As a first
step, we assume macroscopic uniformity, as in [13], such that the periodic auxiliary quantities
are computed over a single periodic cell only once for every point x ∈ ΩH (see Figure 1), via
the solution of Stokes’ and Laplace’s differential problems. For a discussion concerning non-
macroscopic uniformity and the subsequent increase in computational complexity, see, e.g. [17]
and [19], respectively.
3.1. Physiological parameters
The parameters used in the simulations are collected in Table I and Table II. It was not possible
Table I. Parameters characterizing the fluid and drug transport problem.
Symbol Parameter Unit Value Reference
Lp Vessel hydraulic permeability m/(Pa s) 1.78× 10−11 [20]
k Tumor hydraulic conductivity m2/(Pa s) 2.1× 10−13 [21]
µ Blood viscosity Pa s 4.0× 10−3 [22]
d Reference microscale m 4.0× 10−5 [23]
L Reference macroscale m 1.0× 10−2 [24, 20]
C Reference pressure gradient Pa/m 5× 102 [13, 14]
R Tumor radius m 5.0× 10−3 [24, 20]
T Time interval h 96 -
P Vessel wall permeability (ref. drug) m/s 1.7× 10−7 [25, 26]
Dn Diffusivity in the capillaries (ref. drug) m2/s 3.3× 10−10 [14]
Dt Diffusivity in the interstitium (ref. drug) m2/s 1.0× 10−11 [14]
λ Uptake in the interstitium (ref. drug) 1/s 1.07× 10−11 [14]
τ Plasma clearance time constant (ref. drug) h 6 [27]
Table II. Parameters for the two representative drugs.
Symbol Parameter Unit Value Reference
Dvinn Capillary diffusivity (Vinblastine) m2/s 3.3× 10−10 [14]
Dvint Interstitial diffusivity (Vinblastine) m2/s 1.9× 10−12 [14]
P vin Vessel wall permeability (Vinblastine) m/s 1.2× 10−6 [14]
τ vin Plasma clearance time constant (Vinblastine) h 25 [28]
λvin Uptake in the interstitium (Vinblastine) 1/s 1.07× 10−11 [14]
Ddoxn Capillary diffusivity (Doxorubicin) m2/s 4.8× 10−10 [29]
Ddoxt Interstitial diffusivity (Doxorubicin) m2/s 5.01× 10−11 [30]
P dox Vessel wall permeability (Doxorubicin) m/s 1.95× 10−6 [31]
τ dox Plasma clearance time constant (Doxorubicin) h 22.5 [32, 33]
λdox Uptake in the interstitium (Doxorubicin) 1/s 5.8× 10−5 [30]
to find in the literature an estimate for two parameters, namely the reflection coefficient σ and the
transvascular Pe´cle´t number Pe. Regarding the first, we follow the work in [34, chap. 7], where σ is
Copyright c© 2010 John Wiley & Sons, Ltd. Int. J. Numer. Meth. Biomed. Engng. (2010)
Prepared using cnmauth.cls DOI: 10.1002/cnm
THE VASCULAR ROLE ON DIFFUSION AND CONSUMPTION OF ANTI-CANCER DRUGS 9
calculated from the mathematical expression:
σ =
16
3
α2 − 20
3
α3 +
7
3
α4, α =
rmol
rpor
(32)
and the constant α is given by the ratio between the molecule and the pore radii in the capillary
membrane. According to the observations in [20], we estimate rpor = 1.0µm, a value consistent
with the multiple fenestrations that characterize a malignant vascular network. The molecule radius
can be estimated from the Stokes-Einstein equation:
rmol =
kBT
6piµDmol
(33)
where kBT is the Boltzmann thermal energy. We find rvin = 2.98× 10−8m and rdox = 1.13×
10−9m for Vinblastine and Doxorubicin radii, respectively. Using these estimates for the radii, we
obtain the values σvin = 4.56× 10−3 and σdox = 6.8× 10−6 via Equation (32). The value of the
transvascular Pe´cle´t number can be obtained from the relation in Section 2, assuming:
Pe = γΦb =
(
1− σ
P
)
(Lp∆p) (34)
where ∆p is a suitable value for the pressure difference between the capillary and interstitial
compartments. According to [20], we take ∆p ≈ 103 Pa and obtain the estimate Pe ≈ 10−2 using
the numbers in Tables I and II. This value suggests to consider the linear regime proposed in
Equation (13) for the drug flux Φ¯d, indicating that drug exchange is mainly due to diffusion across
the capillary membrane for this kind of molecules.
From the parameters in table I and II it is also possible to provide an estimate for the value of the
non-dimensional number Π¯ in Equation (14). Using the highest value for σ, we find:
Π¯ =
LpLµσRTCr
Cd3
' 0.05 `
mol
× Cr (35)
Since a realistic value for the reference concentration of the drugs that we considered is given
by Cr ' 1÷ 10× 10−6 mol/` [35, 36], we obtain the estimate Π¯ ' 5÷ 50× 10−8. We can thus
simplify the expression for the fluid flux in Equation (10), which now reads:
Φ¯b = L¯p (pn − pt) (36)
Φ¯d = (1− σ) c¯ Φ¯b + Υ¯ (cn − ct) (37)
where we have also reported the updated expression for the drug flux.
3.2. Periodic cell problems’ solution for a tortuous microvasculature
In [13], the cell problems related to the hydraulic conductivity tensors K and E are discussed in
detail. The authors evaluate the influence of the blood vessels’ tortuosity on fluid transport in the
tumor tissue. In particular, they consider different unit cells varying the vessels’ tortuosity and track
the changes in hydraulic conductivities of the capillary and interstitial compartments. This way, they
qualitatively and quantitatively describe the hampering effect of vascular geometrical complexity
Copyright c© 2010 John Wiley & Sons, Ltd. Int. J. Numer. Meth. Biomed. Engng. (2010)
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on fluid convection. Following this approach, here we focus on the solution of the cell problems
for the effective diffusivities Dn and Dt given by (27-28) and (29-30), respectively. Each of the
latter vectorial Laplace problems, which are in terms of a and b, is equivalent to three standard
scalar Laplace problems for the components a1, a2, a3 and b1, b2, b3, respectively. According to the
analysis reported in [13], we note that an isotropic problem for the concentrations at the macroscale
can be obtained if the effective diffusivity tensors satisfy the relations:
Dn = D˜nI, Dt = D˜tI (38)
with D˜n and D˜t given by:
D˜n = An
(
1− 〈∂a1
∂y1
〉n
)
= An
(
1− 〈∂a2
∂y2
〉n
)
= An
(
1− 〈∂a3
∂y3
〉n
)
(39)
D˜t = At
(
1− 〈∂a1
∂y1
〉
)
= At
(
1− 〈∂a2
∂y2
〉n
)
= At
(
1− 〈∂a3
∂y3
〉n
)
(40)
In order to satisfy the isotropic representations reported above, we select the same microstructures
exploited in [13], which are characterized by three orthogonal branches and invariance under
permutations of the three coordinate axes. The latter feature leads to the following componentwise
relationships
∂a3
∂y1
=
∂a1
∂y2
=
∂a2
∂y3
,
∂b3
∂y1
=
∂b1
∂y2
=
∂b2
∂y3
(41)
∂a3
∂y2
=
∂a1
∂y3
=
∂a2
∂y1
,
∂b3
∂y2
=
∂b1
∂y3
=
∂b2
∂y1
(42)
∂a3
∂y3
=
∂a1
∂y1
=
∂a2
∂y2
,
∂b3
∂y3
=
∂b1
∂y1
=
∂b2
∂y2
. (43)
Hence, we only need to solve two scalar Laplace’s problems, for example in terms of a3 and b3 as
reported below.
∇2ya3 = 0 in Ωn (44)
∇ya3 · n = n3 on Γ (45)
∇2yb3 = 0 in Ωt (46)
∇yb3 · n = n3 on Γ (47)
〈a3〉n = 0 in Ωn, 〈b3〉t = 0 in Ωt. (48)
We then recover the full solution for Dn and Dt through the definitions in Equation (25) and
exploiting relationships (41). As expected from the analysis of the Stokes’ probles reported in
[13], the chosen microstructure geometry reflects in negligible extra-diagonal components, when
compared to the diagonal ones. We therefore account for the isotropic representations (39) and
(40) for the purpose of our analysis. As done in [13] for the hydraulic conductivity, the impact of
tortuosity is tested on the effective diffusivities by varying the geometrical configurations of Ωn and
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Ωt. We introduce two parameters, A and ω, that lead to different tortuosity in the vascular network
through an analytical parametrization of the capillary centerline. The representative capillary
network cell portion is shown in Figure 2. The capillary and interstitial cell problems are solved
Figure 2. An example of the tortuous capillary network cell portion is shown on the left. The paramters l
and rc are the one-sided branch length and capillary radius, respectively, [13]. The corresponding three-
dimensional mesh and the analytical parametrization of the capillary centerline is shown on the right.
Reprinted from The Journal of Theoretical Biology, Volume 364, The role of microvascular tortuosity in
tumor transport phenomena, Pages No. 80-97, Copyright (2015), with permission from Elsevier.
via the commercial finite element software COMSOL Multiphysics, where Equations (44)-(48) are
discretized by standard P2 elements. By selecting different values of the tortuosity parametersA and
ω we vary the geometrical tortuosity of the representative cell and then we compute the values of the
effective diffusivities Dn and Dt. Results are presented in Table III, where we report the values of
the effective diffusivities for geometries with different tortuosity, together with the corresponding
values for S, |Ωn| and |Ωt|. Comparison between the two extreme tortuosity regimes (from now
Table III. Computational results for the non-dimensional capillary and interstitial diffusivities Dn and Dt,
cell exchange surface S and capillary and interstitial cell volume portions |Ωn| and |Ωt|. With reference to
Figure 2, three geometries with varying tortuosity are tested, parametrized by different values of ω.
ω A D˜n/An D˜t/At S |Ωn| |Ωt|
0 0 3.6× 10−1 1 2.30 8.1× 10−2 6.149
1 0.25rc 3.57× 10−1 1 2.30 8.0× 10−2 6.15
1 0.5rc 3.53× 10−1 1 2.30 7.9× 10−2 6.151
1 0.75rc 3.4× 10−1 1 2.31 7.8× 10−2 6.152
1 rc 3.19× 10−1 1 2.32 7.6× 10−2 6.154
2 0.25rc 3.54× 10−1 1 2.30 7.9× 10−2 6.151
2 0.5rc 3.18× 10−1 1 2.33 7.6× 10−2 6.154
2 0.75rc 2.65× 10−1 1 2.42 7.2× 10−2 6.158
2 rc 2.13× 10−1 1 2.57 6.9× 10−2 6.161
3 0.25rc 3.37× 10−1 1 2.32 7.8× 10−2 6.152
3 0.5rc 2.47× 10−1 1 2.53 7.2× 10−2 6.158
3 0.75rc 1.59× 10−1 1 2.82 6.8× 10−2 6.162
3 rc 0.9× 10−1 1 3.25 6.5× 10−2 6.165
on named “Regular” and “Tortuous”) shows that, even for a regular microvasculare, there exists an
almost 3-fold drop in capillary effective diffusivity with respect to the base value. For the tortuous
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case, we observe an up to 10-fold decrease. Concerning the interstitium, we note that the effective
diffusivity is not affected by the variation of geometry. This is consistent with the results in [13],
where a similar behavior is observed for the effective hydraulic conductivity E (which is likewise
computed via problem (46-47) and it is indeed equivalent to
1
At
Dt) as long as |Ωn|  |Ω|, where
|Ω| = |Ωn|+ |Ωt|.
3.3. Macroscale governing equations for a spherical tumor
We assume that the tissue scale tumor geometry can be represented by a sphere of radius R.
The tumor is supposed to be isolated, consisting of a vascularized mass that interacts with the
environment only through the substances transported by the microvasculature. The influence of
an external stress or biochemical activity is neglected, and we focus mainly on the effect of vascular
tortuosity on the transport of injected drugs. Enforcing radial symmetry, the Equations for the
leading order drug concentrations (5)-(6) read:
∂cn
∂t
+
1
r2
∂
∂r
[
r2
(
uncn − D˜n ∂cn
∂r
)]
= − S|Ωn| Φ¯d (49)
∂ct
∂t
+
1
r2
∂
∂r
[
r2
(
utct − D˜t ∂ct
∂r
)]
=
S
|Ωt| Φ¯d −Da ct (50)
where each variable is a function of the radial coordinate r and of the time t. The latter is supposed
to span the interval (0, T ), while r covers the tumor domain, namely 0 ≤ r ≤ R. Here the radial
components of the capillary and interstitial velocities un and ut are given by solution of the
fluid transport problems in [13], corresponding to Equations (3)-(4) and (7)-(8). We assume that
drug capillary concentration drives drug evolution in the interstitium. This is imposed by selecting
suitable boundary conditions. To this end, we model a bolus injection of drug in the tumor vessels
by fixing the concentration in the capillaries at r = R. This concentration decreases exponentially
with time according to the plasma clearance time constant τ (see [27]). Concerning the interstitial
compartment, we assume that the drug does not diffuse into the outer tissue. Symmetry at the tumor
center implies a null drug flux in r = 0. Finally, assuming that no drug is present at the beginning
of the simulation in both compartments, the complete set of initial and boundary conditions is given
by:
cn
∣∣
t=0
= ct
∣∣
t=0
= 0 (51)(
uncn − D˜n∂rcn
)∣∣
r=0
=
(
utct − D˜t∂rct
)∣∣
r=0
= 0 (52)
cn
∣∣
r=R
= exp(−t/τ), −D˜t∂rct
∣∣
r=R
= 0. (53)
The governing Equations of the macroscale model in (49)-(53) are discretized via the finite element
program COMSOL Multiphysics. The spatial discretization is carried out via standard P2 elements,
whereas for the discretization in time an implicit BDF method is used.
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4. RESULTS AND DISCUSSION
We investigate the role of the geometrical properties of the microvasculature on the capillary
diffusivity and consumption of an injected drug. We model the drug dynamics by means of the
homogenized mathematical model illustrated in the previous sections, thus extending the previous
work developed in [13]. In sections 4.1-3 we consider the simplified form of Equation (37) given
by:
Φ¯d = Υ¯ (cn − ct) (54)
where we neglect the convective contribution to the drug flux. The effect of the latter contribution
(which in the experimental literature is usually encoded in the diffusive membrane permeability for
the sake of convenience) on the drug distribution profiles will be evaluated separately in section 4.4.
The results are presented in terms of the tumor drug concentration ct (and related quantities) against
the relative radius rˆ = r/R.
4.1. Effects of diffusion and uptake on drug distribution
The cell problems in (44)-(48) are solved in three dimensional space for different complexities of the
microvascular geometries. The resulting diffusivity tensors are injected into the macroscale model
(49)-(50) to track the evolution of drug concentration in the tumor. Results from the simulations
corresponding to the parameters in Table I are displayed in Figure 3 and 4. We consider the
dynamics of a generic drug, focusing on the effects of diffusion on drug transport. We report a
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Figure 3. Regular microvasculature, drug distribution in the presence (solid lines) or absence (dashed lines)
of the diffusion damping effect.
significant decrease in capillary diffusivity for increasing tortuosity of the microvascular network.
Compared to the base value An, we observe a 3-fold drop in the case of a regular microvasculature
and an up to 10-fold reduction in the most tortuous vascular network (see Table III). The decrease
in molecule diffusivity can be observed comparing the solid and dashed lines in Figure 3.a and 3.b,
where the drug interstitial concentration ct is represented as a function of tumor relative radius rˆ
for different times. Both figures are determined for a regular microvasculature, but for the dashed
lines the diffusivity tensors Dn and Dt are taken equal to the base values An and At, respectively.
On the other hand, for the solid lines the two tensors are obtained solving the cell problems and
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Figure 4. Tortuous microvasculature, drug distribution in the presence (solid lines) or absence (dashed lines)
of the diffusion damping effect.
calculating the integrals in Equations (39)-(40). Note that even though the diffusivity is reduced,
the molecule transport is not fully compromised. This is due to the regular microvasculature and
the corresponding unimpaired hydraulic conductivity. Fluid convection is still functional and this
enables the tumor interior to be reached by the drug after a certain time. The effect of network
tortuosity is displayed clearly in Figure 4.a and 4.b, where the same comparison is carried out for
a tortuous microvasculature. In this case both molecule diffusivity and advection are compromised,
and also drug uptake proves significantly altered. In particular, a reduced effective diffusivity is
responsible for a more compact drug distribution that travels towards the center of the tumor. This
produces local values of ct that are higher than their not-damped counterparts, as shown more clearly
in Figure 2 of [15].
4.2. Analysis of two representative drugs
In this section the mathematical model is tested against two representative drugs, commonly found
in the clinical literature. The first medication, Vinblastine, is an antimicrotubule drug generally used
to treat a variety of cancers, including Hodgkin’s lymphoma, non-small cell lung cancer, breast
cancer, head and neck cancer, and testicular cancer [37]. Via binding with tubulin, the molecule
inhibits assembly of microtubules and leads to cell death. The second molecule that we consider
is Doxorubicin, a chemotherapeutic agent used to treat several cancers including blood cancers
and many types of carcinoma [38]. The primary mechanism of action of Doxorubicin is DNA
intercalation with the subsequent halting of the process of cell replication. The parameters used
in the simulations are collected in Table II. Note that, despite some of the molecule parameters
are very similar (e.g. the diffusion coefficients and the plasma clearance), the uptake rate of the
molecules greatly differ between the two drugs. Vinblastine behaves like a tracer molecule, with
a small absorption in the tissue, while the Doxorubicin uptake rate is several orders of magnitude
higher. The evolution of Vinblastine interstitial concentration is shown in Figure 5 vs the radius
of the tumor and for different times in the interval (0− 96h). In this case molecule distribution is
strongly dictated by the fluid dynamics of the two compartments. According to the results reported
in Figure 5.a for a regular microvasculature, the molecule is able to travel for a long distance into the
tumor before being washed away from the system. At the end of the simulation, a small portion of
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Figure 5. Vinblastine dynamics for a regular (a) and a tortuous (b) microvasculature.
the drug reaches the center of the tumor and interacts with the cancer cells. On the other hand, Figure
5.b shows the effect of a tortuous microvasculature on the drug dynamics. The radius reached by the
molecule is considerably smaller when compared to the regular case (see 5.a) and after four days no
drug is present in the tumor center. The geometrical complexity of the network is also responsible
for the decrease in molecular diffusion. As a consequence, the drug concentration profile is more
localized in space (see Figure 5) and this effect contributes in impairing drug transport in the internal
portion of the tumor.
The case of Doxorubicin is dramatically different. This molecule interacts strongly with the
interstitial compartment and its dynamic is dominated by tissue uptake. Figure 6 represents the
interstitial concentration of Doxorubicin versus time and tumor radius. Here the effect of a regular
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Figure 6. Doxorubicin dynamics for a regular (a) and a tortuous (b) microvasculature.
(6.a) or tortuous (6.b) microvasculature is less relevant for the evolution of the system. With reaction
dominating the scene, the timescale of the phenomena is shifted towards shorter times. The effects
of convection and diffusion, for which the complexity of the microvasculature plays a main role,
operates at later times and the two dynamics do not overlap. As a result, the concentration profile is
almost independent from the geometrical complexity of the vascular network, and the effectiveness
of the drug has to be evaluated using different indexes (an example of which will be given in
Section 4.3). Note that for a molecule of this kind a therapy focusing only on the improvement
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of mass transport in the tumor may be inadequate, and additional measures should be undertaken to
guarantee better drug efficacy.
4.3. Metabolized drug
From a clinical perspective, the interstitial concentration of a drug may not be a significant proxy
for evaluating the treatment performance. In this section we introduce the auxiliary quantity M(r),
to account for the quantity of drug metabolized in the tumor as a function of its radius. This quantity
is defined as:
M(r) =
∫ T
0
R [ct(r, t
′)] dt′ (55)
where T is the time interval considered in the simulations and R [·] is the reaction term in Equation
(6). For linear uptake, as the one considered in this work, the latter term reads:
M(r) =
∫ T
0
Da ct(r, t′) dt′ (56)
with Da being the Damko¨hler number calculated in Equation (14). In Figure 7 this quantity is plotted
for the two molecules examined in the previous section. Figure 7.a shows the results for Vinblastine.
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Figure 7. Metabolized drug for Vinblastine (a) and Doxorubicin (b). Solid lines refer to a regular
microvasculature, dashed lines to a tortuous one.
Here the solid line indicates the case of a regular microvasculature, while the dashed line stands for
the tortuous case. There is a marked difference between the two vascular regimes, both in terms of
curve amplitudes and maxima locations. Regarding the first result, more drug is metabolized in a
regular network, with a value different from zero also in the tumor center. The curve peak is shifted
from the outer boundary of the tissue towards the tumor center, as fluid convection is still effective.
Conversely, for a tortuous microvasculature the amount of metabolized drug is less and is delimited
to the first half of the domain, near the tumor boundary. Diffusion and convection are hindered due
to the geometrical complexity of the network, and at the end of the simulation a negligible quantity
of drug is able to reach the cancer cells located in the tumor center.
The case of Doxorubicin is shown in Figure 7.b. Again, solid and dashed lines describe a regular
and a tortuous microvasculature, respectively. For Doxorubicin, the maximum value of M(r) is
greater than the corresponding value for Vinblastine. This results from the high value of the
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Damko¨hler number in this second molecule with respect to Vinblastine. The amount of metabolized
drug decays almost exponentially from the border of the tumor towards its center, where the value
is about 10% of the maximum. Even though the two curves are very similar, we note smaller values
of M(r) in the case of a tortuous microvasculature over all the tumor radius.
4.4. Convective contribution to the drug flux
In the previous sections we have only considered the diffusive contribution to the drug exchange
across the capillary membrane. However, in general, we should also account for the convective
contribution to the drug flux (cf. relationship (37)), which is proportional to the pressure difference
between the two tissue compartments. However, the complete formulation for the drug flux is rarely
implemented in the literature. The experimental measurement of the vessel diffusive permeability
P is actually extremely complex, since it should account only for the diffusive portion of the drug
flux, neglecting the convective counterpart. Thus, this second contribution to the flux is generally
ignored in the modeling literature and an higher effective permeability Peff is instead considered. In
this Section we take into account the complete formulation (37) for the drug flux, and compare the
results with the previously implemented approximation. The corresponding results are displayed
in Figure 8 for a regular (8.a) and a tortuous (8.b) microvasculature. We use the parameters of
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Figure 8. Comparison between the two drug fluxes Φd proposed in the model. The parameters are those
of Vinblastine and a regular (a) and a tortuous microvasculature (b) are considered. The two cases with
a complete drug flux or with a purely diffusive contribution are represented by solid or dotted lines
respectively.
Vinblastine from Section 3.1. The evolution of the system is similar to the previous case in Figure 5,
reported in Figure 8 with dotted lines. The qualitative dynamics of the system are similar to the case
where we account for a diffusive contribution only. We observe an analogous concentration drop due
to the hindered fluid flow in the tortuous network, combined with the same decrease in molecule
diffusivity. The effects of the new term in Equation (37) become apparent when we compare the
amplitude of the curves. The new drug flux law provides a lower concentration over the whole tumor
domain and for each considered time interval. At a first glance these results seem counterintuitive, as
we could expect that an increase in (fluid-driven) drug convection across the capillary walls should
result in a corresponding increase of drug concentration in the tumor mass. A possible explanation
of this phenomenon may be given recalling the experimental observations of Jain and coworkers on
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the role of vessel permeability in tumor angiogenesis [27, 6, 20, 5]. Jain and his group carry out a
series of experiments where they evaluate the permeability of capillary membranes in tumor vessels
- a measure of Lp in our equations - and link this quantity with the fluid dynamics in the tumors.
They observe that even though tumor vessels are characterized by high permeabilities, the exchange
of fluids and solutes across vessel membranes is markedly hampered. This occurs as the pressure
gradients between capillaries and interstitium cancel out due to the altered fluid exchange, and the
corresponding fluid flow vanishes. Moreover, since the lymphatic system in the tumor is usually not
functional, the fluid stagnates in the interstitium and an equilibrium condition is reached. A similar
mechanism characterizes our system: a greater flow of drug, allowed by Equation (37), leads to a
faster balance between the drug concentration in the two compartments. The equilibrium is met at
shorter times, contributing to lower drug levels.
5. CONCLUSIONS AND FUTURE PERSPECTIVES
In this work, we analyze the impact of microvascular tortuosity on drug diffusion and uptake in
a solid tumor. Drug dynamics are described at the tissue scale, considering both the capillary
and interstitial compartments. Our modeling framework allows us to track the key drug transport
properties (such as absorption and diffusion) and their dependence on the microstructure. The model
derivation is based on asymptotic homogenization and exploits the sharp length separation existing
between the spatial scales characterizing the tumor tissue. As a result, the geometrical information at
the microscale are encoded into four tensor quantities, namely the effective hydraulic conductivities
and diffusivities, which are computed via solution of three dimensional simulations defined over a
single representative cell. These coefficients are then injected into the macroscale equations, which
describe the evolution of drug distribution in the tumor at the tissue scale.
According to the results presented here, the model predicts impaired drug transport in the tumor
for increasing geometrical complexity of the vascular network. We observe that only a small
portion of the injected drug is able to reach the tumor center, due to decreased fluid convection
and drug diffusion. We have investigated the effect of tortuosity on two reference molecules used
by clinicians, namely Vinblastine and Doxorubicin. The results show a remarkable difference
between these two drugs, due to their different interaction with the tumor interstitium. The first
drug (Vinblastine) acts like a tracer molecule, with almost negligible uptake rate. In this case, the
evolution of the drug is dominated by transport in the capillaries, and we observe a clear effect
of tortuosity on molecule advection and diffusion. In contrast, the second molecule (Duxorubicin)
is characterized by a higher uptake rate in the interstitium, and the effects of vascular network
geometry on drug evolution are negligible. The observations about these molecules are confirmed
by analyzing the amount of drug metabolized in the tumor, a quantity that provides a valuable index
for the effectiveness of a particular therapeutic agent.
Finally, we conclude our study by introducing an additional term into the drug flux equation,
accounting for convective transport of molecules through the semipermeable membrane of the
capillaries. Our results show a decreased distribution of the drug within the tumor, a phenomenon
similar to what is observed with fluid exchange across a malignant capillary network.
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We point out that these results refer to specific anti-cancer agents and that the general problem
is non-trivial due to the mutual influence of the large number of parameters involved. A sensitivity
analysis leading to a more thorough understanding of model predictions would be therefore crucial
to elucidate the interplay between drug transport and geometrical tortuosity for different molecules
and physiological scenarios (the latter possibly involving complex, nonlinear fluid and mass
exchange across the capillary walls and metabolic reactions). However, these examples clearly show
that the dependence of drug transport properties on the geometrical features of the microvasculature
cannot be ignored.
This work is certainly open to a number of improvements. In particular, we have assumed
macroscopic uniformity to reduce computational complexity and solve the various cell problems
only once for each tortuous configuration. However, in general, the tumor microvasculature is not
periodic and this assumption should be relaxed to simulate a macroscopically non-periodic vascular
network considering the full model [9]. In this case, one cell problem for each macroscale point
should be solved, and the challenge resides in the development of efficient algorithms, which should
couple macro and micro spatial variations via parallel computing together with adequate image
segmentation. Alternatively, for a range of simplified microstructure, it is possible to parametrically
vary the parameter(s) (such as the radius of circular objects) characterizing the microscale geometry,
as done for example in [39] for advection-diffusion of solute through a macroscopically varying
porous structure made of circular obstacles. Note that the solutions obtained in this work, as it
usually happens for models that make use of asymptotic homogenization, are usually good over the
domain interior, but may be inaccurate in regions close to the domain boundary. This could be due
to a lack of y-periodicity at the border, or to other issues as reported in [40]. A possible solution for
this problem can be found in [40, 41], where the authors propose a set of correctors to improve the
solutions at the boundaries. The existing homogenized model should also be significantly extended
to capture the nanoparticles dynamics as a drug delivery vector and their adhesion to the tortuous
capillary walls. Numerical results obtained from such a model could be then compared with those
presented in the context of the immersed boundary method [42] (based on the fluid transport
model [43]), where a simplified, 1D representation of the vascular network is taken into account.
This comparison would clarify the impact of the hydraulic properties of the microvasculature on
nanomolecules adhesion.
Finally, this work represents one more significant step towards a novel framework that may
improve the design and efficacy of anticancer strategies. As a next, natural step, this modeling
framework and its future generalization should be applied in the context of realistic geometries
obtained from medical images to enable validation of the results and provide reliable hints to the
clinicians’ community.
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